Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Pulmonary Hypertension, September 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 135 articles:
HTML format


 

Single Articles

  1. DENIWAR A, Hernandez J, Aregullin EO, Khan SK, et al
    Atrial septal defect-associated pulmonary hypertension with decompensated heart failure: outcomes after fenestrated device closure - CORRIGENDUM.
    Cardiol Young. 2023 Sep 1:1. doi: 10.1017/S1047951123003281.
    PubMed    


  2. ZENG X, Wu Z, Cen C, Wen S, et al
    Thrombosis is not the only determinant of chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2023 Aug 29:131304. doi: 10.1016/j.ijcard.2023.131304.
    PubMed    


  3. PARGANA J, Cale R, Martinho M, Santos J, et al
    Prevalence and predictors of chronic thromboembolic pulmonary hypertension following severe forms of acute pulmonary embolism.
    Rev Port Cardiol. 2023 Aug 29:S0870-2551(23)00392.
    PubMed    


  4. KURNICK A, Zaveri S, Tadayoni A, Chandrakumar HP, et al
    Reversible severe pulmonary hypertension and right heart failure with cardiogenic shock due to scurvy: a case report.
    Eur Heart J Case Rep. 2023;7:ytad404.
    PubMed    
    Abstract available

  5. NAFEES B, de Freitas HM, Beaudet A, Todd E, et al
    A Health State Utility Study to Elicit Societal Values Associated with Pulmonary Hypertension.
    Patient Prefer Adherence. 2023;17:2119-2130.
    PubMed    
    Abstract available

  6. DIMITRY MO, Soliman YMA, ElKorashy RI, Raslan HM, et al
    Role of micro-RNAs 21, 124 and other novel biomarkers in distinguishing between group 1 WHO pulmonary hypertension and group 2, 3 WHO pulmonary hypertension.
    Egypt Heart J. 2023;75:76.
    PubMed    
    Abstract available

  7. TSIAMITA O, White K
    Post-thrombotic syndrome and chronic thromboembolic pulmonary hypertension: diagnosis and management.
    Br J Hosp Med (Lond). 2023;84:1-10.
    PubMed    
    Abstract available

  8. GENG Y, Hu Y, Zhang F, Tuo Y, et al
    Mitochondria in hypoxic pulmonary hypertension, roles and the potential targets.
    Front Physiol. 2023;14:1239643.
    PubMed    
    Abstract available

  9. WU Y, Tian P, Liang L, Chen Y, et al
    Improved Prognostic Performance of Right Atrial Pressure-Corrected Cardiac Power Output in Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction.
    J Cardiovasc Transl Res. 2023 Aug 29. doi: 10.1007/s12265-023-10429.
    PubMed    
    Abstract available

  10. ZHANG W, Liu Z, Lin W, Zhang F, et al
    [Diagnosis and treatment of a child with alveolar capillary dysplasia with misalignment of pulmonary veins due to variant of FOXF1 gene].
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2023;40:1171-1175.
    PubMed    
    Abstract available

  11. MIZUNO R, Uesugi A, Yamazaki M
    Giant pulmonary artery aneurysm in long-standing chronic thromboembolic pulmonary hypertension.
    Eur Heart J Cardiovasc Imaging. 2023 Aug 29:jead217. doi: 10.1093.
    PubMed    


  12. DENG XX, Jin BW, Li SS, Zhou HM, et al
    Pulmonary hypertension- a novel phenotypic hypothesis of Kabuki syndrome: a case report and literature review.
    BMC Pediatr. 2023;23:429.
    PubMed    
    Abstract available

  13. ISHIDA M, Yamamura A, Fujiwara M, Amano T, et al
    Pimaric acid reduces vasoconstriction via BK(Ca) channel activation and VDCC inhibition in rat pulmonary arterial smooth muscles.
    J Pharmacol Sci. 2023;153:84-88.
    PubMed    
    Abstract available

  14. WU H, Huan C, Hu Y, Xiao S, et al
    Development and validation of a nomogram for predicting all-cause mortality in patients with hemodialysis having pulmonary hypertension.
    Cardiorenal Med. 2023 Aug 28. doi: 10.1159/000533674.
    PubMed    
    Abstract available

  15. WU XC, Ye FL, Zheng XZ
    Fetal pulmonary artery stiffness is a strong predictor of persistent pulmonary hypertension of the newborn - An echocardiographic study.
    Eur J Obstet Gynecol Reprod Biol. 2023;289:60-64.
    PubMed    
    Abstract available

  16. ESPARHAM A, Shoar S, Mehri A, Modukuru VR, et al
    Bariatric Surgery and Cardiovascular Disease Risk in Patients with Pulmonary Hypertension: A Propensity Score Matched Analysis of US National Inpatient Sample.
    Obes Surg. 2023 Aug 28. doi: 10.1007/s11695-023-06799.
    PubMed    
    Abstract available

  17. WANG H, Zhou X, Xiong C
    A rare etiology of pulmonary hypertension-pulmonary tumor thrombotic microangiopathy.
    Eur Heart J Cardiovasc Imaging. 2023 Aug 28:jead219. doi: 10.1093.
    PubMed    


  18. OLIVEIRA AC, Karas MM, Alves M, He J, et al
    ACE2 overexpression in corticotropin-releasing-hormone cells offers protection against pulmonary hypertension.
    Front Neurosci. 2023;17:1223733.
    PubMed    
    Abstract available

  19. KERKUTLUOGLU M, Gunes H, Atilla N, Celik E, et al
    Relationship Between Soluble ST2 Level and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) in Acute Pulmonary Embolism (PE) Patients.
    Cureus. 2023;15:e42449.
    PubMed    
    Abstract available

  20. WANG LJ, Feng F, Li JC, Chen TT, et al
    Role of heparanase in pulmonary hypertension.
    Front Pharmacol. 2023;14:1202676.
    PubMed    
    Abstract available

  21. DUAN A, Huang Z, Zhao Z, Zhao Q, et al
    The potential of cystatin C as a predictive biomarker in pulmonary hypertension.
    BMC Pulm Med. 2023;23:311.
    PubMed    
    Abstract available

  22. KAULINS R, Rudzitis A, Lejnieks A, Kigitovica D, et al
    Baseline Clinical Characteristics and Incidence of Chronic Thromboembolic Pulmonary Hypertension Patients in Latvia, 2019-2020.
    Medicina (Kaunas). 2023;59:1426.
    PubMed    
    Abstract available

  23. SANCHEZ-GLORIA JL, Martinez-Olivares CE, Del Valle-Mondragon L, Cortes-Camacho F, et al
    Allicin, an Emerging Treatment for Pulmonary Arterial Hypertension: An Experimental Study.
    Int J Mol Sci. 2023;24:12959.
    PubMed    
    Abstract available

  24. PULLAMSETTI SS, Sitapara R, Osterhout R, Weiss A, et al
    Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2023;24:12653.
    PubMed    
    Abstract available

  25. DILLON K, Lamba V, Philip RR, Weems MF, et al
    Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
    Children (Basel). 2023;10:1397.
    PubMed    
    Abstract available

  26. MANDOLI GE, Landra F, Chiantini B, Sciaccaluga C, et al
    Tricuspid Regurgitation Velocity and Mean Pressure Gradient for the Prediction of Pulmonary Hypertension According to the New Hemodynamic Definition.
    Diagnostics (Basel). 2023;13:2619.
    PubMed    
    Abstract available

  27. CONTI M, Minniti M, Tine M, De Francesco M, et al
    Extracellular Vesicles in Pulmonary Hypertension: A Dangerous Liaison?
    Biology (Basel). 2023;12:1099.
    PubMed    
    Abstract available

  28. MARTIN G, Canuet M, Rahli M, Schuller A, et al
    Severe pre-capillary pulmonary hypertension associated with kyphoscoliosis: Description of 4 cases.
    Respir Med Res. 2023;84:101034.
    PubMed    


  29. ISHIDA H, Maeda J, Uchida K, Yamagishi H, et al
    Unique Pulmonary Hypertensive Vascular Diseases Associated with Heart and Lung Developmental Defects.
    J Cardiovasc Dev Dis. 2023;10:333.
    PubMed    
    Abstract available

  30. STERINGER-MASCHERBAUER R, Huber C, Froschl U, Engleder D, et al
    Intravenous Treprostinil in Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension Using Implantable Pumps-Single-Center Experience over More Than a Decade.
    J Cardiovasc Dev Dis. 2023;10:318.
    PubMed    
    Abstract available

  31. CHAI L, Wang Q, Wang Y, Li D, et al
    Downregulation of PDCD4 through STAT3/ATF6/autophagy mediates MIF-induced PASMCs proliferation/migration and vascular remodeling.
    Eur J Pharmacol. 2023;956:175968.
    PubMed    
    Abstract available

  32. WOOD KP, Fleming GA, Chamberlain RC
    Update on Transcatheter Device Closure of Congenital Septal Defects.
    Curr Cardiol Rep. 2023;25:1083-1093.
    PubMed    
    Abstract available

  33. SFERRA SR, Guo M, Gonzalez Salazar AJ, Penikis AB, et al
    Sex-specific Differences in Congenital Diaphragmatic Hernia Mortality.
    J Pediatr. 2023 May 15:113481. doi: 10.1016/j.jpeds.2023.113481.
    PubMed    
    Abstract available

  34. WEI Q, Chen W, Liang Q, Song S, et al
    Effect of Endotracheal Suctioning on Infants Born through Meconium-Stained Amniotic Fluid: A Meta-Analysis.
    Am J Perinatol. 2022 Jan 11. doi: 10.1055/s-0041-1741034.
    PubMed    
    Abstract available

  35. HUANG H, Yang L
    Research Progress of Inflammatory Factors in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension at High Altitude.
    Altern Ther Health Med. 2023 Sep 8:AT9086.
    PubMed    
    Abstract available

  36. LOAR RW, Tsao C, Ogunyankin F, Wilkes JK, et al
    Mid-Systolic Notching of the Pulmonary Valve Doppler Signal is Highly Associated with Pulmonary Hypertension.
    Pediatr Cardiol. 2023 Sep 7. doi: 10.1007/s00246-023-03285.
    PubMed    
    Abstract available

  37. BRAAMS NJ, Kianzad A, van Wezenbeek J, Wessels JN, et al
    Long-Term Effects of Pulmonary Endarterectomy on Right Ventricular Stiffness and Fibrosis in Chronic Thromboembolic Pulmonary Hypertension.
    Circ Heart Fail. 2023 Sep 7:e010336. doi: 10.1161/CIRCHEARTFAILURE.122.010336.
    PubMed    
    Abstract available

  38. FAIRCLOTH JM, Bhatt ND, Chartan CA, Coleman RD, et al
    Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration.
    Front Pediatr. 2023;11:1275389.
    PubMed    
    Abstract available

  39. HONORE PM, Bousbiat I, Perriens E, Blackman S, et al
    Chronic thromboembolic pulmonary hypertension: early recognition leads to optimal therapy and drastically decreases mortality!
    Ann Transl Med. 2023;11:340.
    PubMed    


  40. LICHTBLAU M, Titz A, Bahrampoori B, Schmiedeskamp M, et al
    What changed after the 2022 guidelines for pulmonary hypertension?
    Eur J Intern Med. 2023 Sep 4:S0953-6205(23)00305.
    PubMed    
    Abstract available

  41. TSUTSUI M
    [Protective role of the nitric oxide synthases system in inter-organ communication].
    Nihon Yakurigaku Zasshi. 2023;158:374-378.
    PubMed    
    Abstract available

  42. DARDI F, Rotunno M, Guarino D, Suarez SM, et al
    Comparison of different treatment strategies in patients with chronic thromboembolic pulmonary hypertension: A single centre real-world experience.
    Int J Cardiol. 2023 Sep 4:131333. doi: 10.1016/j.ijcard.2023.131333.
    PubMed    
    Abstract available

  43. YU X, Qin W, Lin X, Shan Z, et al
    Synergizing the enhanced RIME with fuzzy K-nearest neighbor for diagnose of pulmonary hypertension.
    Comput Biol Med. 2023;165:107408.
    PubMed    
    Abstract available

  44. HOU C, Wen DM, Wang J
    [Advances in neuromodulation of pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:936-940.
    PubMed    
    Abstract available

  45. GIRALDO-RAMIREZ S, Gandara-Ricardo JA, Velasquez-Penagos J, Florez-Munoz J, et al
    [Once in a blue moon: coronavirus disease complicates pregnancy in a patient with unknown pulmonary hypertension and subsequent left ventricular dysfunction].
    Arch Cardiol Mex. 2023 Sep 5. doi: 10.24875/ACM.22000089.
    PubMed    
    Abstract available

  46. GODA A, Takeuchi K, Kikuchi H, Inami T, et al
    Pulmonary artery pressure-perfusion relation during exercise in patients with chronic thromboembolic pulmonary hypertension using pulmonary arteriography and right-heart catheterization.
    Int J Cardiol Heart Vasc. 2023;48:101252.
    PubMed    
    Abstract available

  47. ZHAO F, Chen Y, Xie Y, Kong S, et al
    Identification of Zip8-correlated hub genes in pulmonary hypertension by informatic analysis.
    PeerJ. 2023;11:e15939.
    PubMed    
    Abstract available

  48. SHAN X, Wang J, Feng H, Zhang Z, et al
    Aloperine Protects Pulmonary Hypertension via Triggering PPARgamma Signaling and Inhibiting Calcium Regulatory Pathway in Pulmonary Arterial Smooth Muscle Cells.
    Am J Physiol Cell Physiol. 2023 Sep 4. doi: 10.1152/ajpcell.00286.2023.
    PubMed    
    Abstract available

  49. CERNY V, Pagac J, Novak M, Jansa P, et al
    Semi-automatic quantification of mosaic perfusion of lung parenchyma and its correlation with haemodynamic parameters in patients with chronic thromboembolic pulmonary hypertension.
    Clin Radiol. 2023 Aug 23:S0009-9260(23)00365-3. doi: 10.1016/j.crad.2023.
    PubMed    
    Abstract available

  50. CAMPOS-CARRARO C, Turck P, de Lima-Seolin BG, Teixeira RB, et al
    Copaiba oil improves pulmonary nitric oxide bioavailability in monocrotaline-treated rats.
    Can J Physiol Pharmacol. 2023;101:447-454.
    PubMed    
    Abstract available

  51. HARUTYUNOVA S, Benjamin N, Eichstaedt C, Marra AM, et al
    Long-Term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension.
    Respiration. 2023;102:579-590.
    PubMed    
    Abstract available

  52. SAINT-MARTIN WILLER A, Santos-Gomes J, Adao R, Bras-Silva C, et al
    Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart.
    J Physiol. 2023;601:3717-3737.
    PubMed    
    Abstract available

  53. SUNGUR A, Sungur MA, Karagoz A, Sert Sekerci S, et al
    Cardiohepatic syndrome and its prognostic predictive ability in patients with pulmonary arterial hypertension.
    Scand J Clin Lab Invest. 2023;83:290-298.
    PubMed    
    Abstract available

  54. ROTONDO C, Sciacca S, Rella V, Busto G, et al
    Subclinical coronary atherosclerosis, detected by computer tomography with coronary calcium score, and the occurrence of major cardiovascular events at 5 years of follow-up in a cohort of patients with systemic sclerosis.
    Eur J Intern Med. 2023;115:62-69.
    PubMed    
    Abstract available

  55. WUNDER F, Stasch JP, Knorr A, Mondritzki T, et al
    Identification and characterization of the new generation soluble guanylate cyclase stimulator BAY-747 designed for the treatment of resistant hypertension.
    Br J Pharmacol. 2023;180:2500-2513.
    PubMed    
    Abstract available

  56. MA J, Li C, Zhai Z, Zhen Y, et al
    Distribution of thrombus predicts severe reperfusion pulmonary edema after pulmonary endarterectomy.
    Asian J Surg. 2023;46:3766-3772.
    PubMed    
    Abstract available

  57. HOEPER MM
    Extracorporeal Life Support in Pulmonary Hypertension: Practical Aspects.
    Semin Respir Crit Care Med. 2023 Sep 14. doi: 10.1055/s-0043-1772752.
    PubMed    
    Abstract available

  58. BARATTO C, Caravita S, Vachiery JL
    Pulmonary Hypertension Associated with Left Heart Disease.
    Semin Respir Crit Care Med. 2023 Sep 14. doi: 10.1055/s-0043-1772754.
    PubMed    
    Abstract available

  59. ALQARNI AA, Aldhahir AM, Bintalib HM, Alqahtani JS, et al
    Inhaled therapies targeting prostacyclin pathway in pulmonary hypertension due to COPD: systematic review.
    Front Med (Lausanne). 2023;10:1217156.
    PubMed    
    Abstract available

  60. AKIN EJ, Aoun J, Jimenez C, Mayne K, et al
    ANO1, CaV1.2, and IP3R form a localized unit of EC-coupling in mouse pulmonary arterial smooth muscle.
    J Gen Physiol. 2023;155:e202213217.
    PubMed    
    Abstract available

  61. STEWART S, Chan YK, Playford D, Harris S, et al
    Incident pulmonary hypertension in 13 488 cases investigated with repeat echocardiography: a clinical cohort study.
    ERJ Open Res. 2023;9:00082-2023.
    PubMed    
    Abstract available

  62. KURIYAMA A, Kasai H, Sugiura T, Nagata J, et al
    Clinical significance of lung cross-sectional area measured by computed tomography in chronic thromboembolic pulmonary hypertension: The correlation with pulmonary hemodynamics and the limitations.
    Pulm Circ. 2023;13:e12287.
    PubMed    
    Abstract available

  63. ZHANG X, Guo X, Zhang B, Yang Q, et al
    The Role of Strain by Cardiac Magnetic Resonance Imaging in Predicting the Prognosis of Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Clin Appl Thromb Hemost. 2023;29:10760296231176253.
    PubMed    
    Abstract available

  64. GARCIA RU, Beshish A, Butto A, Kanaan U, et al
    Continuous Prostanoid Initiation in Severe Pulmonary Hypertension in the Pediatric Cardiac Intensive Care Unit.
    Pediatr Cardiol. 2023 Sep 12. doi: 10.1007/s00246-023-03282.
    PubMed    
    Abstract available

  65. LUO F, Fu M, Wang T, Qi Y, et al
    Down-regulation of the mitochondrial fusion protein Opa1/Mfn2 promotes cardiomyocyte hypertrophy in Su5416/hypoxia-induced pulmonary hypertension rats.
    Arch Biochem Biophys. 2023;747:109743.
    PubMed    
    Abstract available

  66. BIRD E, Hasenstab K, Kim N, Madani M, et al
    Mapping the Spatial Extent of Hypoperfusion in Chronic Thromboembolic Pulmonary Hypertension Using Multienergy CT.
    Radiol Cardiothorac Imaging. 2023;5:e220221.
    PubMed    
    Abstract available

  67. RAMANAND P, Indic P, Gentle SJ, Ambalavanan N, et al
    Information Based Similarity Analysis of Oxygen Saturation Recordings to Detect Pulmonary Hypertension in Preterm Infants.
    Biomed Signal Process Control. 2023;86.
    PubMed    
    Abstract available

  68. QU J, Li M, Zhang X, Zhang M, et al
    A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
    Respir Res. 2023;24:220.
    PubMed    
    Abstract available

  69. YANG Y, Yang B, Liu B, Liang Y, et al
    Circulating choline levels are associated with prognoses in patients with pulmonary hypertension: a cohort study.
    BMC Pulm Med. 2023;23:313.
    PubMed    
    Abstract available

  70. GONZALEZ-HERMOSILLO LM, Cueto-Robledo G, Navarro-Vergara DI, Roldan-Valadez E, et al
    Prevalence and prognosis of hypothyroidism in patients with chronic thromboembolic pulmonary hypertension: an updated review with description of case series.
    Curr Probl Cardiol. 2023 Sep 7:102069. doi: 10.1016/j.cpcardiol.2023.102069.
    PubMed    


  71. FAZELIFAR AF, Talebian F, Ghaffarinejad Z, Habibi MA, et al
    Electrocardiographic manifestations of pulmonary stenosis versus pulmonary hypertension.
    J Electrocardiol. 2023;81:117-122.
    PubMed    
    Abstract available

  72. GUERRA-OJEDA S, Suarez A, Valls A, Verdu D, et al
    The Role of Aryl Hydrocarbon Receptor in the Endothelium: A Systematic Review.
    Int J Mol Sci. 2023;24:13537.
    PubMed    
    Abstract available

  73. BASSAREO PP, D'Alto M
    Metabolomics in Pulmonary Hypertension-A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology.
    Int J Mol Sci. 2023;24:13227.
    PubMed    
    Abstract available

  74. PELAIA C, Armentaro G, Lupia C, Maiorano A, et al
    Effects of High-Flow Nasal Cannula on Right Heart Dysfunction in Patients with Acute-on-Chronic Respiratory Failure and Pulmonary Hypertension.
    J Clin Med. 2023;12:5472.
    PubMed    
    Abstract available

  75. PEZZUTO B, Agostoni P
    The Current Role of Cardiopulmonary Exercise Test in the Diagnosis and Management of Pulmonary Hypertension.
    J Clin Med. 2023;12:5465.
    PubMed    
    Abstract available

  76. YANG J, Zhou F, Zhou X, Sun Y, et al
    Survival and prognosis analysis of systemic lupus erythematosus patients with pulmonary hypertension: A systematic review and meta-analysis.
    Medicine (Baltimore). 2023;102:e34947.
    PubMed    
    Abstract available

  77. OTA H, Higuchi S
    Editorial for "Multicenter Standardization of Phase Resolved Functional Lung MRI in Patients With Suspected Chronic Thromboembolic Pulmonary Hypertension".
    J Magn Reson Imaging. 2023 Sep 8. doi: 10.1002/jmri.28992.
    PubMed    


  78. FUJIWARA T, Takeda N, Hara H, Ishii S, et al
    PGC-1alpha-mediated angiogenesis prevents pulmonary hypertension in mice.
    JCI Insight. 2023;8:e162632.
    PubMed    
    Abstract available

  79. LACHANT D, Minkin R, Swisher J, Mogri M, et al
    Safety and efficacy of transitioning from selexipag to oral treprostinil in pulmonary arterial hypertension: Findings from the ADAPT registry.
    Pulm Pharmacol Ther. 2023;82:102232.
    PubMed    
    Abstract available

  80. GOKCEN N
    Serum markers in systemic sclerosis with cardiac involvement.
    Clin Rheumatol. 2023;42:2577-2588.
    PubMed    
    Abstract available

  81. YI D, Liu B, Ding H, Li S, et al
    E2F1 Mediates SOX17 Deficiency-Induced Pulmonary Hypertension.
    Hypertension. 2023 Sep 22. doi: 10.1161/HYPERTENSIONAHA.123.21241.
    PubMed    
    Abstract available

  82. PAWAR SG, Khan N, Salam A, Joshi M, et al
    The association of Pulmonary Hypertension and right ventricular systolic function -updates in diagnosis and treatment.
    Dis Mon. 2023 Sep 19:101635. doi: 10.1016/j.disamonth.2023.101635.
    PubMed    
    Abstract available

  83. TURESH K, Tanisha, Soojal, Rajani D, et al
    Comment on: Impact of Pulmonary Hypertension in Patients with Hypertrophic Cardiomyopathy Presented with Cardiogenic Shock / Acute Decompensated Heart Failure.
    Curr Probl Cardiol. 2023 Sep 19:102091. doi: 10.1016/j.cpcardiol.2023.102091.
    PubMed    


  84. MOHER ALSADY T, Voskrebenzev A, Behrendt L, Olsson K, et al
    Multicenter Standardization of Phase-Resolved Functional Lung MRI in Patients With Suspected Chronic Thromboembolic Pulmonary Hypertension.
    J Magn Reson Imaging. 2023 Sep 21. doi: 10.1002/jmri.28995.
    PubMed    
    Abstract available

  85. FUKUDA Y, Shimokawahara H, Chikama S, Watanabe A, et al
    Combination of rescue balloon pulmonary angioplasty and riociguat therapy for chronic thromboembolic pulmonary hypertension with nonsustained polymorphic ventricular tachycardia: A case report.
    Pulm Circ. 2023;13:e12290.
    PubMed    
    Abstract available

  86. COLGLAZIER E, Ng AJ, Parker C, Woolsey D, et al
    Safety and tolerability of continuous inhaled iloprost in critically ill pediatric pulmonary hypertension patients: A retrospective case series.
    Pulm Circ. 2023;13:e12289.
    PubMed    
    Abstract available

  87. ZHAO H, Wang L, Yan Y, Zhao QH, et al
    Identification of the shared gene signatures between pulmonary fibrosis and pulmonary hypertension using bioinformatics analysis.
    Front Immunol. 2023;14:1197752.
    PubMed    
    Abstract available

  88. LI M, Shi Y, Zhao J, Wang Q, et al
    Identification of potential susceptibility genes in patients with primary Sjogren's syndrome-associated pulmonary arterial hypertension through whole exome sequencing.
    Arthritis Res Ther. 2023;25:175.
    PubMed    
    Abstract available

  89. KLINGER JR, Wu B, Morland K, Classi P, et al
    Burden of pulmonary hypertension due to chronic obstructive pulmonary disease: Analysis of exacerbations and healthcare resource utilization in the United States.
    Respir Med. 2023 Sep 18:107412. doi: 10.1016/j.rmed.2023.107412.
    PubMed    
    Abstract available

  90. CONDLIFFE R, Newton R, Bauchmuller K, Bonnett T, et al
    Surgery and Anesthesia in Patients with Pulmonary Hypertension.
    Semin Respir Crit Care Med. 2023 Sep 20. doi: 10.1055/s-0043-1772753.
    PubMed    
    Abstract available

  91. IGNATIUK D, Miles K, Gurbani N, Hossain MM, et al
    Occurrence of sleep-disordered breathing in children with pulmonary hypertension.
    Pediatr Pulmonol. 2023 Sep 20. doi: 10.1002/ppul.26693.
    PubMed    
    Abstract available

  92. FRONRATH MJ, Hencken L, Martz CR, Kelly B, et al
    Fluid Resuscitation and Relation to Respiratory Support Escalation in Patients with and without Pulmonary Hypertension with Sepsis.
    Pharmacotherapy. 2023 Sep 20. doi: 10.1002/phar.2879.
    PubMed    
    Abstract available

  93. YOGESWARAN A, Rako ZA, Yildiz S, Ghofrani HA, et al
    Echocardiographic evaluation of right ventricular diastolic function in pulmonary hypertension.
    ERJ Open Res. 2023;9:00226-2023.
    PubMed    
    Abstract available

  94. SWINNEN K, Verstraete K, Baratto C, Hardy L, et al
    Machine learning to differentiate pulmonary hypertension due to left heart disease from pulmonary arterial hypertension.
    ERJ Open Res. 2023;9:00229-2023.
    PubMed    
    Abstract available

  95. MOORE SS, De Carvalho Nunes G, Dancea A, Wutthigate P, et al
    Early cardiac function and death, severe bronchopulmonary dysplasia and pulmonary hypertension in extremely preterm infants.
    Pediatr Res. 2023 Sep 19. doi: 10.1038/s41390-023-02817.
    PubMed    
    Abstract available

  96. BHATIA M, Scheiber CJ, Arora S, Gustafson C, et al
    Should All Patients With Pulmonary Hypertension Undergoing Non-Cardiac Surgery Be Managed by Cardiothoracic Fellowship-Trained Anesthesiologists?
    Semin Cardiothorac Vasc Anesth. 2023 Sep 19:10892532231203128.
    PubMed    
    Abstract available

  97. LIU JN, Zhao ZG, Luo FM
    Pulmonary hypertension-related dynamic left ventricular outflow tract obstruction.
    Eur Heart J. 2023 Sep 19:ehad605. doi: 10.1093.
    PubMed    


  98. JOYA-SEIJO MD, Garrido-Lestache MEB, Rueda-Camino JA, Angelina-Garcia M, et al
    External validation of the InShape II study algorithm for exclusion of chronic thromboembolic pulmonary hypertension in patients with pulmonary thromboembolism.
    Rev Clin Esp (Barc). 2023 Sep 16:S2254-8874(23)00105.
    PubMed    
    Abstract available

  99. KAZMIRCZAK F, Thenappan T, Prins KW, Prisco SZ, et al
    Sex differences in right ventricular function between Groups 1 and 3 pulmonary hypertension.
    Pulm Circ. 2023;13:e12288.
    PubMed    
    Abstract available

  100. ZHAO F, Pan C, Zhang Y, Yang J, et al
    Polyphyllin VII alleviates pulmonary hypertension by inducing miR-205-5p to target the beta-catenin pathway.
    Biomed Pharmacother. 2023;167:115516.
    PubMed    
    Abstract available

  101. GARCIA AR, Blanco I, Ramon L, Perez-Sagredo J, et al
    Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry.
    Respir Res. 2023;24:223.
    PubMed    
    Abstract available

  102. WAWRZYNIAK R, Biesemans M, Kugacka-Dabrowska A, Lewicka E, et al
    Plasma untargeted metabolomics with proteinase K discloses phospholipid signature associated with pulmonary arterial hypertension.
    Sci Rep. 2023;13:15280.
    PubMed    
    Abstract available

  103. VORA K, Dharmakumar R
    Editorial Commentary for State-of-the-Art Cardiac Magnetic Resonance in Pulmonary Hypertension - An Update on Diagnosis, Risk Stratification and Treatment.
    Trends Cardiovasc Med. 2023 Sep 13:S1050-1738(23)00076.
    PubMed    


  104. ZHAO Q, Liu Z, Song P, Yuan Z, et al
    Mitochondria Derived Vesicle Packaging as a Novel Therapeutic Mechanism in Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2023 Sep 15. doi: 10.1165/rcmb.2023-0010.
    PubMed    
    Abstract available

  105. MATSUGI E, Takashima S, Doteguchi S, Kobayashi T, et al
    Real-world safety and effectiveness of inhaled nitric oxide therapy for pulmonary hypertension during the perioperative period of cardiac surgery: a post-marketing study of 2817 patients in Japan.
    Gen Thorac Cardiovasc Surg. 2023 Sep 15. doi: 10.1007/s11748-023-01971.
    PubMed    
    Abstract available

  106. GHAREPAPAGH E, Rahimi F, Koohi A, Bakhshandeh H, et al
    Clot Burden As a Predictor of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism: A Cohort Study.
    Thorac Res Pract. 2023;24:276-281.
    PubMed    
    Abstract available

  107. HUANG Z, Cheng X, Lin B, Zhao J, et al
    Diameter of ductus arteriosus on postnatal Day 7 is associated with late pulmonary hypertension in extremely preterm infants.
    Pediatr Pulmonol. 2023 Sep 15. doi: 10.1002/ppul.26686.
    PubMed    
    Abstract available

  108. KRISHNAN M, Desjardin JT, Vaidya A, DE Marco T, et al
    Reproductive Care in Pulmonary Arterial Hypertension.
    J Card Fail. 2023;29:1314-1318.
    PubMed    


  109. HUMBERT M, Sitbon O, Guignabert C, Savale L, et al
    Treatment of pulmonary arterial hypertension: recent progress and a look to the future.
    Lancet Respir Med. 2023;11:804-819.
    PubMed    
    Abstract available

  110. KITTIPIBUL V, Agarwal R
    The Many Sides of Right Heart Dysfunction: Exploring Exercise Markers in Heart Failure with Preserved Ejection Fraction versus Pulmonary Arterial Hypertension.
    J Card Fail. 2023 Jun 22:S1071-9164(23)00225.
    PubMed    


  111. WU Y, Tian P, Liang L, Chen Y, et al
    Combined use of right ventricular coupling and pulmonary arterial elastance as a comprehensive stratification approach for right ventricular function.
    Clin Transl Sci. 2023;16:1582-1593.
    PubMed    
    Abstract available

  112. AROOR S, Handattu K, Mundkur SC, Verma A, et al
    Severe Pulmonary Arterial Hypertension in Healthy Young Infants: Single Center Experience.
    Indian Pediatr. 2023;60:748-751.
    PubMed    
    Abstract available

  113. ISHISAKA Y, Watanabe A, Takagi H, Takayama H, et al
    Use of Perioperative Extracorporeal Membranous Oxygenation in Pulmonary Endarterectomy Cases: A Systematic Review and Meta-Analysis.
    J Intensive Care Med. 2023;38:785-796.
    PubMed    
    Abstract available

  114. OKA H, Sumitomo S, Shimizu H, Kanamori M, et al
    Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy.
    Intern Med. 2023;62:2747-2751.
    PubMed    
    Abstract available

  115. BEHROOZ L, Barillas-Lara M, Fattouh M, Loubeau B, et al
    The role of invasive cardiopulmonary exercise testing in patients with unexplained dyspnea: a systemic review.
    Acta Cardiol. 2023;78:754-760.
    PubMed    
    Abstract available

  116. RZECHORZEK W, Dey S, Shah A, Michaud L, et al
    High-Risk Pulmonary Hypertension Does Not Worsen Outcomes in Heart Transplantation.
    Am J Cardiol. 2023;205:290-297.
    PubMed    
    Abstract available

  117. ALPERT MA
    Beneficial Effects of Inspiratory Muscle Training in Patients With Pulmonary Arterial Hypertension.
    Am J Cardiol. 2023 Aug 7:S0002-9149(23)00689.
    PubMed    


  118. SHEN CP, Bagsic SRS, Pandey AC
    Strain and Exercise-Induced Pulmonary Hypertension.
    Am J Cardiol. 2023;205:442-444.
    PubMed    


  119. ATHANASSOPOULOS GD, Armenis I
    A Glimpse for Venous Congestion Management in Pulmonary Hypertension by POCUS of Portal Vein Flow.
    Am J Cardiol. 2023 Sep 1:S0002-9149(23)00783.
    PubMed    


  120. LU D, Cheng CY, Zhu XJ, Li JY, et al
    Heart Rate Response Predicts 6-Minutes Walking Distance in Pulmonary Arterial Hypertension.
    Am J Cardiol. 2023;204:207-214.
    PubMed    
    Abstract available

  121. AGOSTONI P, Mattavelli I
    The Pulmonary Hypertension Treatment: Dogmas and Ghosts.
    Am J Cardiol. 2023 Sep 19:S0002-9149(23)00963.
    PubMed    


  122. CASCINO TM, Schopfer DW, Meyer CS, Zhang N, et al
    Exercise Rehabilitation is Underutilized Among Veterans With Pulmonary Hypertension.
    Am J Cardiol. 2023;207:4-6.
    PubMed    


  123. ALMAZROUE H, Jin Y, Nelin LD, Barba JC 2nd, et al
    Human pulmonary microvascular endothelial cell DDAH1-mediated nitric oxide production promotes pulmonary smooth muscle cell apoptosis in co-culture.
    Am J Physiol Lung Cell Mol Physiol. 2023;325:L360-L367.
    PubMed    
    Abstract available

  124. FARHA S, Aldred MA
    Regulating the Regulators: Epigenetic Modulation of Regulatory T-Cells in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2023 Sep 8. doi: 10.1164/rccm.202308-1456.
    PubMed    


  125. GUO M, Wikenheiser-Brokamp KA, Kitzmiller JA, Jiang C, et al
    Single Cell Multiomics Identifies Cells and Genetic Networks Underlying Alveolar Capillary Dysplasia.
    Am J Respir Crit Care Med. 2023;208:709-725.
    PubMed    
    Abstract available

  126. NORLANDER AE, Abney M, Cephus JY, Roe CE, et al
    Prostaglandin I(2) Therapy Promotes Regulatory T Cell Generation in Patients with Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2023;208:737-739.
    PubMed    


  127. RANASINGHE ADCU, Holohan M, Borger KM, Donahue DL, et al
    Altered Smooth Muscle Cell Histone Acetylome by the SPHK2/S1P Axis Promotes Pulmonary Hypertension.
    Circ Res. 2023 Sep 12. doi: 10.1161/CIRCRESAHA.123.322740.
    PubMed    
    Abstract available

  128. KUEHN BM
    Experimental Drug, Combination Pill Show Promise for Treating Pulmonary Hypertension.
    Circulation. 2023;148:852-854.
    PubMed    


  129. MICHELENA HI, Anand V, Enriquez-Sarano M, Pellikka PA, et al
    Correspondence on 'Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes' by Ratwatte et al.
    Heart. 2023 Sep 1:heartjnl-2023-323347. doi: 10.1136/heartjnl-2023-323347.
    PubMed    


  130. RATWATTE S, Celermajer DS
    Response to: Correspondence on 'Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes' by Michelena et al.
    Heart. 2023 Sep 1:heartjnl-2023-323348. doi: 10.1136/heartjnl-2023-323348.
    PubMed    


  131. LOOSEN G, Taboada D, Ortmann E, Martinez G, et al
    How Would I Treat My Own Chronic Thromboembolic Pulmonary Hypertension in the Perioperative Period?
    J Cardiothorac Vasc Anesth. 2023 Jul 21:S1053-0770(23)00504.
    PubMed    
    Abstract available

  132. BROCKMOLLER J, Ivanoski S, Hundack L, Blohm JH, et al
    Clinical and hemodynamic improvement in pulmonary hypertension after switching to sacubitril/valsartan in heart failure patients with preserved ejection fraction.
    J Cardiovasc Pharmacol. 2023 Sep 1. doi: 10.1097/FJC.0000000000001477.
    PubMed    
    Abstract available

  133. YE JR, Hu SY, Lin YH, Huang CH, et al
    Surgery for fibrosing mediastinitis with severe pulmonary hypertension due to pulmonary venous stenosis.
    J Heart Lung Transplant. 2023 Aug 25:S1053-2498(23)02002.
    PubMed    
    Abstract available

  134. TIMBERLINE S, Bhatt A, Sunderji S, Tancredi DJ, et al
    Novel scoring tool of hypoxemic respiratory failure and pulmonary hypertension for defining severity of persistent pulmonary hypertension of newborn.
    J Perinatol. 2023 Aug 25. doi: 10.1038/s41372-023-01762.
    PubMed    
    Abstract available

  135. RAMBARAT P, Zern EK, Wang D, Roshandelpoor A, et al
    Identifying high risk clinical phenogroups of pulmonary hypertension through a clustering analysis.
    PLoS One. 2023;18:e0290553.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.


;